NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Primary Bioscience

Primary Bioscience

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://primarybioscience.com/

Last Round

Seed Round

Jun 23, 2026

Total Funding Raised

$1.13M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Primary Bioscience is a drug discovery company developing the next generation of therapeutics to prevent and treat viral infections.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Medical Devices, Precision Medicine, Drug Discovery

Business Model

B2B

Customer Profile

Usage-Based SaaS, Hardware Sales, Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

protein sequencingsingle-molecule protein sequencingnext-generation protein sequencingproteomics platformmulti-cancer early detectionliquid biopsynanopore sensingSERSbiomarker discoveryunbiased proteomicsproteoform analysissurface-enhanced Raman spectroscopyAI signal decodingdrug developmentPTM analysisrazor and blade model

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Primary Bioscience Comps

Public and private peers based on sector, stage, and business model.

Primary Bioscience comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Primary Bioscience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundJun 23, 2026
SeedOct 1, 2025
AcceleratorJul 7, 2025
GrantOct 9, 2023

Primary Bioscience Investors

Notable investors and investment history

Primary Bioscience investors
InvestorRounds
Creative Destruction LabAccelerator, Seed Round, Seed
IndieBioAccelerator, Seed
Life Science Washington Entrepreneurship & Venture ServicesGrant, Seed Round, Seed
Reinforced VenturesSeed
SOSVAccelerator, Seed Round, Seed
Washington State Department of CommerceGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 23, 2026

    $1.3M seed round completed.

  • Oct 1, 2025

    $1.1M round with SOSV and Reinforced Ventures.

Primary Bioscience Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Primary Bioscience Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Primary Bioscience's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range5
Year Founded2021
Last FundingJun 23, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.